832 related articles for article (PubMed ID: 21896142)
1. Thiazide and loop diuretics.
Sica DA; Carter B; Cushman W; Hamm L
J Clin Hypertens (Greenwich); 2011 Sep; 13(9):639-43. PubMed ID: 21896142
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
Musini VM; Nazer M; Bassett K; Wright JM
Cochrane Database Syst Rev; 2014 May; 2014(5):CD003824. PubMed ID: 24869750
[TBL] [Abstract][Full Text] [Related]
3. Treating essential hypertension. The first choice is usually a thiazide diuretic.
Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
[TBL] [Abstract][Full Text] [Related]
4. First-line diuretics versus other classes of antihypertensive drugs for hypertension.
Reinhart M; Puil L; Salzwedel DM; Wright JM
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD008161. PubMed ID: 37439548
[TBL] [Abstract][Full Text] [Related]
5. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
[TBL] [Abstract][Full Text] [Related]
6. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.
Wright JT; Dunn JK; Cutler JA; Davis BR; Cushman WC; Ford CE; Haywood LJ; Leenen FH; Margolis KL; Papademetriou V; Probstfield JL; Whelton PK; Habib GB;
JAMA; 2005 Apr; 293(13):1595-608. PubMed ID: 15811979
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Wright JT; Harris-Haywood S; Pressel S; Barzilay J; Baimbridge C; Bareis CJ; Basile JN; Black HR; Dart R; Gupta AK; Hamilton BP; Einhorn PT; Haywood LJ; Jafri SZ; Louis GT; Whelton PK; Scott CL; Simmons DL; Stanford C; Davis BR
Arch Intern Med; 2008 Jan; 168(2):207-17. PubMed ID: 18227370
[TBL] [Abstract][Full Text] [Related]
9. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.
Volpe M; Tocci G
Vasc Health Risk Manag; 2012; 8():371-80. PubMed ID: 22745561
[TBL] [Abstract][Full Text] [Related]
10. Thiazide diuretics in the treatment of hypertension: an update.
Salvetti A; Ghiadoni L
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S25-9. PubMed ID: 16565243
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension.
Chen JM; Heran BS; Wright JM
Cochrane Database Syst Rev; 2009 Oct; (4):CD007187. PubMed ID: 19821398
[TBL] [Abstract][Full Text] [Related]
12. Thiazide and thiazide-like diuretics: an opportunity to reduce blood pressure in patients with advanced kidney disease.
Karadsheh F; Weir MR
Curr Hypertens Rep; 2012 Oct; 14(5):416-20. PubMed ID: 22886538
[TBL] [Abstract][Full Text] [Related]
13. Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.
Schroeder EB; Chonchol M; Shetterly SM; Powers JD; Adams JL; Schmittdiel JA; Nichols GA; O'Connor PJ; Steiner JF
Clin J Am Soc Nephrol; 2018 May; 13(5):727-734. PubMed ID: 29572286
[TBL] [Abstract][Full Text] [Related]
14. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
Einhorn PT; Davis BR; Massie BM; Cushman WC; Piller LB; Simpson LM; Levy D; Nwachuku CE; Black HR;
Am Heart J; 2007 Jan; 153(1):42-53. PubMed ID: 17174636
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.
Martins VM; Helal L; Ferrari F; Bottino LG; Fuchs SC; Fuchs FD
Trials; 2019 Dec; 20(1):736. PubMed ID: 31843024
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure-lowering efficacy of loop diuretics for primary hypertension.
Musini VM; Rezapour P; Wright JM; Bassett K; Jauca CD
Cochrane Database Syst Rev; 2015 May; 2015(5):CD003825. PubMed ID: 26000442
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.
Lynch AI; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
Pharmacogenet Genomics; 2009 Jun; 19(6):415-21. PubMed ID: 19352213
[TBL] [Abstract][Full Text] [Related]
18. Comparison of thiazide-like diuretics versus thiazide-type diuretics: a meta-analysis.
Liang W; Ma H; Cao L; Yan W; Yang J
J Cell Mol Med; 2017 Nov; 21(11):2634-2642. PubMed ID: 28631393
[TBL] [Abstract][Full Text] [Related]
19. Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics.
Weir MR; Flack JM; Applegate WB
Am J Med; 1996 Sep; 101(3A):83S-92S. PubMed ID: 8876478
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure lowering efficacy of loop diuretics for primary hypertension.
Musini VM; Rezapour P; Wright JM; Bassett K; Jauca CD
Cochrane Database Syst Rev; 2012 Aug; (8):CD003825. PubMed ID: 22895937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
